BEAM FY 2023 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$378M+520.0% YoY

Gross Profit

$378M100.0% margin

Operating Income

-$176M-46.7% margin

Net Income

-$133M-35.1% margin

EPS (Diluted)

$-1.72

Cash Flow

Operating Cash Flow

-$149M

Free Cash Flow

-$183M

Stock-Based Comp.

$99M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$478M

Stockholders' Equity

$981M

Cash & Equivalents

$436M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$378M	$61M	+520.0%
Gross Profit	$378M	-$251M	+250.7%
Operating Income	-$176M	-$338M	+47.9%
Net Income	-$133M	-$289M	+54.2%